Holen Sie sich die Stockscreener-App
16.51
1.32%
-0.22
Finanzdaten der Aurinia Pharmaceuticals Inc-Aktie (AUPH)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
7.10%
83.22
|
77.70 | 77.11 | 73.47 | 70.01 |
| Cost Of Revenue |
0.77%
6.555
|
6.505 | 8.799 | 8.177 | 7.115 |
| Research and Development |
74.70%
13.05
|
7.47 | - | - | - |
| Costs And Expenses |
1.64%
36.88
|
36.28 | 43.88 | 43.72 | 49.92 |
| Operating Income/Loss |
11.88%
46.34
|
41.42 | 33.24 | 29.75 | 20.08 |
| Income/Loss From Continuing Operations Before Tax |
11.07%
48.79
|
43.92 | 77.11 | 31.96 | 22.16 |
| Income Tax Expense/Benefit, Deferred |
19.76%
11.11
|
9.277 | - | - | - |
| Income Tax Expense/Benefit |
18.83%
11.37
|
9.57 | -175.10 | 0.411 | 0.643 |
| Net Income/Loss |
8.90%
37.41
|
34.35 | 210.79 | 31.55 | 21.51 |
| Basic Average Shares |
1.73%
130.08
|
132.38 | -0.796 | 131.81 | 134.87 |
| Diluted Average Shares |
2.99%
133.53
|
137.64 | -0.259 | 136.01 | 137.53 |
| Basic Earnings Per Share |
11.54%
0.29
|
0.26 | 1.60 | 0.24 | 0.16 |
| Diluted Earnings Per Share |
12.00%
0.28
|
0.25 | 1.53 | 0.23 | 0.16 |
0.84%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):